AbbVie Inc. SEC filings ABBV

AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 23, 2026 Dec 31, 2025
10-K Annual report Feb 20, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 25, 2025 Dec 31, 2024
10-K Annual report Feb 14, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 18, 2024 Dec 31, 2023
10-K Annual report Feb 20, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 21, 2023 Dec 31, 2022
10-K Annual report Feb 17, 2023 Dec 31, 2022
10-K Annual report Feb 18, 2022 Dec 31, 2021
10-K Annual report Feb 19, 2021 Dec 31, 2020
10-K Annual report Feb 21, 2020 Dec 31, 2019
10-K Annual report Feb 27, 2019 Dec 31, 2018
10-K Annual report Feb 16, 2018 Dec 31, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABBV (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
North Chicago, IL
SEC filer status
Large accelerated filer
SEC CIK
1551152

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.